Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI in Japanese COPD Patients
NCT01192191Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2010
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Aug 2010; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01192191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192191.